Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Wheat

Showing results (191-200 of 207) with videos related to

Pageof 21
Sort By:
American Journal of Epidemiology|September 1, 1983
Recurrent urban histoplasmosis, Indianapolis, Indiana, 1980-1981W F Schlech, L J Wheat, J L Ho, et al.
Medicine|November 1, 1990
Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literatureL J Wheat, P A Connolly-Stringfield, R L Baker, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 3, 2001
Multicenter case-control study of risk factors for histoplasmosis in human immunodeficiency virus-infected personsR A Hajjeh, P G Pappas, H Henderson, et al.
Annals of Internal Medicine|April 15, 1993
Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndromeJ Wheat, R Hafner, M Wulfsohn, et al.
AIDS (London, England)|August 16, 2001
Effects of treatment intensification with hydroxyurea in HIV-infected patients with virologic suppressionD V Havlir, P B Gilbert, K Bennett, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 19, 1999
Itraconazole prophylaxis for fungal infections in patients with advanced human immunodeficiency virus infection: randomized, placebo-controlled, double-blind study. National Institute of Allergy and Infectious Diseases Mycoses Study GroupD S McKinsey, L J Wheat, G A Cloud, et al.
Clinical and Vaccine Immunology : CVI|October 11, 2008
Performance characteristics of the platelia Aspergillus enzyme immunoassay for detection of Aspergillus galactomannan antigen in bronchoalveolar lavage fluidS Husain, C J Clancy, M H Nguyen, et al.
The American Journal of Medicine|April 7, 1998
Randomized trial of itraconazole oral solution for oropharyngeal candidiasis in HIV/AIDS patientsJ R Graybill, J Vazquez, R O Darouiche, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 19, 2005
A randomized study of the use of fluconazole in continuous versus episodic therapy in patients with advanced HIV infection and a history of oropharyngeal candidiasis: AIDS Clinical Trials Group Study 323/Mycoses Study Group Study 40Mitchell Goldman, Gretchen A Cloud, Karen D Wade, et al.
Journal of the Pediatric Infectious Diseases Society|June 26, 2021
Prospective Evaluation of Galactomannan and (1→3) β-d-Glucan Assays as Diagnostic Tools for Invasive Fungal Disease in Children, Adolescents, and Young Adults With Acute Myeloid Leukemia Receiving Fungal ProphylaxisBrian T Fisher, Ted Westling, Craig L K Boge, et al.
Pageof 21

Showing results (191-200 of 207) with videos related to

Sort By:
Pageof 21
American Journal of Epidemiology|September 1, 1983
Recurrent urban histoplasmosis, Indianapolis, Indiana, 1980-1981W F Schlech, L J Wheat, J L Ho, et al.
Medicine|November 1, 1990
Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literatureL J Wheat, P A Connolly-Stringfield, R L Baker, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 3, 2001
Multicenter case-control study of risk factors for histoplasmosis in human immunodeficiency virus-infected personsR A Hajjeh, P G Pappas, H Henderson, et al.
Annals of Internal Medicine|April 15, 1993
Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndromeJ Wheat, R Hafner, M Wulfsohn, et al.
AIDS (London, England)|August 16, 2001
Effects of treatment intensification with hydroxyurea in HIV-infected patients with virologic suppressionD V Havlir, P B Gilbert, K Bennett, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 19, 1999
Itraconazole prophylaxis for fungal infections in patients with advanced human immunodeficiency virus infection: randomized, placebo-controlled, double-blind study. National Institute of Allergy and Infectious Diseases Mycoses Study GroupD S McKinsey, L J Wheat, G A Cloud, et al.
Clinical and Vaccine Immunology : CVI|October 11, 2008
Performance characteristics of the platelia Aspergillus enzyme immunoassay for detection of Aspergillus galactomannan antigen in bronchoalveolar lavage fluidS Husain, C J Clancy, M H Nguyen, et al.
The American Journal of Medicine|April 7, 1998
Randomized trial of itraconazole oral solution for oropharyngeal candidiasis in HIV/AIDS patientsJ R Graybill, J Vazquez, R O Darouiche, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 19, 2005
A randomized study of the use of fluconazole in continuous versus episodic therapy in patients with advanced HIV infection and a history of oropharyngeal candidiasis: AIDS Clinical Trials Group Study 323/Mycoses Study Group Study 40Mitchell Goldman, Gretchen A Cloud, Karen D Wade, et al.
Journal of the Pediatric Infectious Diseases Society|June 26, 2021
Prospective Evaluation of Galactomannan and (1→3) β-d-Glucan Assays as Diagnostic Tools for Invasive Fungal Disease in Children, Adolescents, and Young Adults With Acute Myeloid Leukemia Receiving Fungal ProphylaxisBrian T Fisher, Ted Westling, Craig L K Boge, et al.
Pageof 21